PAP Therapy Sleep Apnea and Exercise

February 6, 2013 updated by: meral uyar, University of Gaziantep

Effects of Positive Airway Pressure Therapy on Exercise Parameters in Obstructive Sleep Apnea

Positive airway pressure (PAP) therapy is generally offered to patients with obstructive sleep apnea. The investigators suggest that beneficial effects of PAP therapy is by preventing apneas and therefore reducing cardiac and pulmonary morbidities. The investigators sought to verify this by assessing cardiac and pulmonary function during exercise.

Study Overview

Status

Completed

Study Type

Observational

Enrollment (Actual)

65

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Gaziantep, Turkey, 27310
        • University of Gaziantep, Faculty of Medicine, Dept. of Pulmonary Diseases

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

All consecutive patients newly diasgnosed with obstructive sleep apnea in whom CPAP therapy was indicated

Description

Inclusion Criteria:

  • obstructive sleep apnea diagnosed by polysomnography
  • CPAP therapy indicated

Exclusion Criteria:

  • obstructive or restrictive lung disease
  • cardiac failure
  • acute coronary syndrome
  • inability to cycle

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Control
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
CPAP compliant
CPAP (continuous positive airway pressure) compliant patients
CPAP non-compliant
patients who did not use CPAP therapy

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
peak oxygen uptake
Time Frame: 30-60 days
30-60 days

Secondary Outcome Measures

Outcome Measure
Time Frame
ventilatory equivalent for carbon dioxide at anaerobic threshold
Time Frame: 30-60 days
30-60 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Meral Uyar, Assoc Prof, University of Gaziantep
  • Principal Investigator: Nazan Bayram, Assis Prof, University of Gaziantep

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2010

Primary Completion (Actual)

July 1, 2011

Study Completion (Actual)

July 1, 2011

Study Registration Dates

First Submitted

February 5, 2013

First Submitted That Met QC Criteria

February 6, 2013

First Posted (Estimate)

February 7, 2013

Study Record Updates

Last Update Posted (Estimate)

February 7, 2013

Last Update Submitted That Met QC Criteria

February 6, 2013

Last Verified

February 1, 2013

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obstructive Sleep Apnea

3
Subscribe